SACK1A and neoplasm: Studies has demonstrated that FAM83A has a high expression capacity in malignancies such as lung cancer, liver cancer, and pancreatic cancer and is associated with tumor proliferation, metastasis, invasion, drug resistance, and epithelial stromal transformation.